Appropriate Dose Selection - How to Optimize Clinical Drug Development
-
- $119.99
-
- $119.99
Publisher Description
Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers – based on the (known) pharmacology of the drug and/or biology of the underlying disease – along with exposure–response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.
More Books Like This
Principles of Biomedical Sciences and Industry
2022
Design and Analysis of Clinical Trials
2013
The Role of the Study Director in Nonclinical Studies
2014
The FDA should Not Mandate Comparative-Effectiveness Trials (Health Policy Outlook)
2011
Off-label Prescribing
2014
Innovative Methods for Rare Disease Drug Development
2020